COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 19:03, il y a 11 mois 9 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 3,700 of its 'A' Ordinary Shares on the London Stock Exchange as part of its share buyback programme London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited 'A' Ordinary Shares
BRÈVE publiée le 24/11/2025 à 19:01, il y a 11 mois 10 jours Director Purchase at Fuller, Smith & Turner PLC Director Shareholding Share Purchase Non-Executive Director Fuller, Smith & Turner EU Market Abuse Regulation
BRÈVE publiée le 24/11/2025 à 19:01, il y a 11 mois 10 jours Directeur des achats chez Fuller, Smith & Turner PLC Achat D'actions Fuller, Smith & Turner Administrateur Non Exécutif Règlement De L'UE Sur Les Abus De Marché Participation Des Administrateurs
COMMUNIQUÉ DE PRESSE publié le 24/11/2025 à 18:56, il y a 11 mois 10 jours Fuller, Smith & Turner PLC: Director / PDMR Shareholding Fuller, Smith & Turner PLC announced Sir James Fuller, Non-Executive Director, purchased 3,500 'C' Ordinary Shares at £6.32 per share on 24 Nov 2025, in compliance with EU Market Abuse Regulation PDMR Director Shareholding Fuller Smith Turner PLC EU Market Abuse Regulation Sir James Fuller
BRÈVE publiée le 20/11/2025 à 19:16, il y a 11 mois 14 jours Fuller, Smith & Turner Executes Share Buyback London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller’s
BRÈVE publiée le 20/11/2025 à 19:16, il y a 11 mois 14 jours Fuller, Smith & Turner procède à un rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller's Actions Du Trésor
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 19:11, il y a 11 mois 14 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program, holding repurchased shares in Treasury London Stock Exchange Share Buyback Program Treasury Fuller, Smith & Turner PLC Own Shares
BRÈVE publiée le 19/11/2025 à 18:14, il y a 11 mois 15 jours Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Ordinary Shares Share Buyback Fuller, Smith & Turner Treasury Stock
BRÈVE publiée le 19/11/2025 à 18:14, il y a 11 mois 15 jours Fuller, Smith & Turner PLC procède à un rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith & Turner Actions Du Trésor
COMMUNIQUÉ DE PRESSE publié le 19/11/2025 à 18:09, il y a 11 mois 15 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC has purchased 5,169 of its 'A' Ordinary Shares as part of its share buyback programme, with highest price at 640.00GBp and lowest at 636.00GBp London Stock Exchange Ordinary Shares Fuller, Smith & Turner PLC Share Buyback Programme Numis Securities Limited
Publié le 04/11/2026 à 18:00, il y a 5 heures 43 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 5 heures 43 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 6 heures Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 34 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 44 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 1 heure 29 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 1 heure 39 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 04/11/2026 à 19:41, il y a 4 heures 2 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 4 heures 18 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 5 heures 1 minute EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 5 heures 38 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Publié le 04/11/2026 à 17:40, il y a 6 heures 4 minutes Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.26.
